Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
Pierre Fenaux(Saint Louis University Hospital), Lewis R. Silverman(Icahn School of Medicine at Mount Sinai), Eva Hellström‐Lindberg(Karolinska University Hospital), Linda Zimmerman(Université Paris Cité), David R. McKenzie(The University of Sydney), Guillermo Sanz(Instituto de Salud Carlos III), Jay T. Backstrom(Université Paris Cité), Alan F. List(TE Laboratories (Ireland)), John F. Seymour(The Royal Melbourne Hospital), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Steven D. Gore(Yale Cancer Center), Norbert Gattermann(Université Paris Cité), Ghulam J. Mufti(King's College London), Hervé Dombret(University of London Institute in Paris), Ulrich Germing(Heinrich Heine University Düsseldorf), C.L. Beach(Université Paris Cité)
Cited by 963
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k